What is it about?

Retrospective Chart Review: The Feasibility of a Self-Administered Nasal Spray

Featured Image

Why is it important?

To describe the results of a self-administered anesthetic nasal spray developed to target the sphenopalatine ganglion (SPG) for the acute and preventive treatment of chronic migraine.

Perspectives

To describe the results of a self-administered anesthetic nasal spray developed to target the sphenopalatine ganglion (SPG) for the acute and preventive treatment of chronic migraine.

Acquire Publications

Read the Original

This page is a summary of: Retrospective Chart Review: The Feasibility of a Self-Administered Nasal Spray Targeting the Sphenopalatine Ganglion (SPG) in Treatment of Chronic Migraine., Journal of Anesthesia and Anesthetic Drugs, April 2022, Acquire Publications LLC,
DOI: 10.54289/jaad2200105.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page